Who Owns Cozaar?
Cozaar is owned by Merck & Co., a publicly traded American multinational pharmaceutical company. Cozaar is Merck's angiotensin II receptor blocker. Merck is headquartered in Rahway, New Jersey, USA and trades on NYSE (MRK).
Parent Company
Merck & Co.
Founded
1995
Status
Publicly Traded
Headquarters
Rahway, New Jersey, USA
Who Owns Cozaar?
- Parent Company: Merck & Co.
- Ownership Type: Wholly owned
- Company Type: Publicly Traded
- Stock Ticker: NYSE: MRK
| Brand | Parent Company | Ownership Type |
|---|---|---|
| Cozaar | Merck & Co. | Wholly owned |
History of Cozaar
- Founded: 1995
- Founders: Merck & Co. (internal development)
Cozaar was developed by Merck & Co. through extensive research into angiotensin II receptor antagonism for treating hypertension. The drug was approved by the FDA in 1995 as a treatment for high blood pressure. Cozaar represented an important advancement in cardiovascular therapy, offering patients an effective angiotensin II receptor blocker.
The development of Cozaar involved years of research into renin-angiotensin system biology and cardiovascular physiology. Merck conducted extensive clinical trials demonstrating the drug's efficacy in treating hypertension. Cozaar quickly became one of the most prescribed blood pressure medications globally.
Following its initial approval, Cozaar became available in multiple strengths and formulations. The drug's effectiveness in treating high blood pressure made it a standard treatment option for hypertension patients. Cozaar became one of Merck's most successful cardiovascular products.
In recent decades, Cozaar has continued to maintain its position as a leading blood pressure medication. The drug has been approved in numerous countries worldwide and has become a standard therapy for hypertension. Cozaar remains one of the leading angiotensin II receptor blockers in the market.
About Merck & Co.
What does Merck & Co. own?
Merck & Co. owns a portfolio of pharmaceutical products, vaccines, and animal health medicines. Its most significant asset is Keytruda, the world's best-selling prescription medicine approved for more than 40 cancer indications. Other major products include Gardasil (HPV vaccine), Winrevair (pulmonary arterial hypertension), Januvia (diabetes), and Bridion (anesthesia reversal). The Animal Health segment markets veterinary medicines under the Merck Animal Health brand.
Is Merck & Co. publicly traded?
Yes, Merck & Co., Inc. trades on the New York Stock Exchange under ticker symbol MRK. The company has no controlling shareholder, with ownership distributed among institutional investors including Vanguard Group, BlackRock, and State Street.
What is Merck's annual revenue?
In FY2024, Merck reported worldwide sales of $64.2 billion, a 7% increase from FY2023. The Pharmaceutical segment generated approximately $57.4 billion and the Animal Health segment approximately $5.8 billion. Keytruda alone accounted for approximately $29.5 billion in FY2024 sales.
Who is Merck's CEO?
Robert M. Davis has served as Chairman and Chief Executive Officer of Merck & Co. since 2021, succeeding Kenneth Frazier. Davis has led the company's strategy of building a post-Keytruda pipeline through acquisitions and internal research investment.
Is Merck & Co. the same as Merck KGaA?
No. Merck & Co. (NYSE: MRK) and Merck KGaA (a German company) are entirely separate companies with no ownership relationship. The separation dates to 1917, when the U.S. government seized German-owned assets in America during World War I. Merck & Co. uses the MSD name outside the United States and Canada to avoid confusion with the German Merck entity.
What is Keytruda and why is it important to Merck?
Keytruda (pembrolizumab) is a PD-1 immune checkpoint inhibitor that works by blocking a protein that prevents the immune system from attacking cancer cells. First approved in 2014 for melanoma, it has since been approved for more than 40 cancer indications. In FY2024, Keytruda generated approximately $29.5 billion in global sales, making it the world's best-selling prescription medicine and accounting for roughly 46% of Merck's total worldwide sales.
- Founded: 1668
- Headquarters: Rahway, New Jersey, USA
- Company Type: Publicly Traded
- Stock: NYSE: MRK
Where Is Cozaar Made / Based?
- Headquarters: Rahway, New Jersey, USA
- Manufacturing / Operations: United States, Belgium, Germany, Ireland
Brands Owned by Merck & Co.
- Bridion - Prescription medication for reversing neuromuscular blockade during anesthesia, ...
- Emend - Prescription antiemetic medication for preventing nausea and vomiting caused by ...
- Gardasil - Prescription human papillomavirus vaccine for preventing cervical cancer and oth...
- Isentress - Prescription antiretroviral medication for treating HIV infection by inhibiting ...
- Januvia - Prescription diabetes medication for treating type 2 diabetes by increasing insu...
- Keytruda - Prescription immunotherapy medication for treating various cancers by activating...
- Pepcid - Over-the-counter and prescription medication for treating heartburn and acid ref...
- Propecia - Prescription medication for treating male pattern baldness by inhibiting hair lo...
- Singulair - Prescription medication for treating asthma and allergies by reducing inflammati...
- Vaseretic - Prescription combination medication for treating high blood pressure, manufactur...
Cozaar Ownership: Pros & Cons
Advantages
- +Effective angiotensin II receptor blocker for hypertension
- +Proven efficacy in lowering blood pressure
- +Available in multiple strengths for different patient needs
- +Backed by extensive clinical research and safety data
- +Supported by Merck's research capabilities and pharmaceutical expertise
- +Available globally with established distribution networks
- +Improved blood pressure control for hypertension patients
Considerations
- -Potential side effects including dizziness and fatigue
- -Requires regular monitoring of blood pressure and kidney function
- -Not suitable for patients with certain kidney conditions
- -Requires consistent adherence to treatment regimen
- -Competition from other blood pressure medications
- -Potential for drug interactions with other medications
- -May not be effective for all types of hypertension
Frequently Asked Questions About Cozaar
Where to Buy
Disclosure: We may earn commission from purchases
Cozaar on AmazonCompetitors to Cozaar
These competing brands operate in the same categories and provide similar products or services. Compare key attributes to understand market positioning and competitive landscape.
| Brand | Parent Company | Country | Founded | Market Position | Primary Market | Gender Target |
|---|---|---|---|---|---|---|
| Novartis | Switzerland | 2009 | Mass Market | Global | All Genders | |
| Takeda | Japan | 2018 | Mass Market | Asia Pacific | All Genders | |
| Pfizer | USA | 1998 | Mass Market | North America | All Genders | |
| Roche | Switzerland | 1995 | Mass Market | Global | All Genders | |
| Novartis | Switzerland | 2015 | Mass Market | Global | All Genders | |
| Cvs Health | USA | 1963 | Mass Market | North America | All Genders |
Learn More About Competitors
Afinitor
Owned by Novartis
Prescription oncology medication for treating various cancers including renal cell carcinoma and breast cancer, manufactured and marketed by Novartis.
Alofisel
Owned by Takeda Pharmaceutical Company
Prescription cell therapy for treating complex perianal fistulas in Crohn's disease, manufactured and marketed by Takeda Pharmaceutical Company.
Celebrex
Owned by Pfizer
Prescription anti-inflammatory medication for treating arthritis pain and inflammation, manufactured and marketed by Pfizer.
CellCept
Owned by Roche
Prescription immunosuppressant medication for preventing organ rejection in transplant recipients, manufactured and marketed by Roche.
Cosentyx
Owned by Novartis
Prescription biologic medication for treating autoimmune diseases including psoriasis, psoriatic arthritis, ankylosing spondylitis, hidradenitis suppurativa, and other inflammatory conditions.
CVS Pharmacy
Owned by CVS Health
American pharmacy retail chain and one of the largest pharmacy networks in the United States, owned by CVS Health.
Competitive Analysis
Market Positioning: Cozaar competes with 6 brands in the same categories, ranging from mass market to luxury positioning.
Geographic Distribution: Competitors are headquartered across multiple regions, indicating global competition in this market segment.
Brand Heritage: Competitor brands range from established heritage brands to newer market entrants, with founding years spanning several decades.
Merck & Co. Stock Information
Jobs at Merck & Co.
Latest News About Cozaar
Related Articles About Cozaar
View more articles
Pharmaceutical Brand Ownership: A Complete Guide
Who makes your medications? Discover which corporations own the biggest pharmaceutical brands, from Ozempic to Tylenol, and how pharma M&A affects you.
Monthly M&A Roundup: February 2026 Brand Ownership Changes
From Keurig Dr Pepper's planned split to the Netflix-WBD saga, here is every major brand ownership change and deal in February 2026.
The Most Acquired Categories: Tech vs CPG vs Pharma
Which industries see the most brand acquisitions? We compared technology, consumer goods, and pharmaceuticals to find out where the most M&A activity happens and why.
People Also Searched
Discover popular brands and companies in the Healthcare & Pharmaceuticals category and related searches from other users.
Activase
Prescription thrombolytic medication for treating acute myocardial infarction and stroke, manufactured and marketed by Roche.
Acuvue
American brand of contact lenses and vision care products specializing in daily disposable and extended wear contact lenses, manufactured and marketed by Johnson & Johnson.
Adcetris
Prescription antibody-drug conjugate for treating Hodgkin lymphoma and other CD30-positive lymphomas, manufactured and marketed by Takeda Pharmaceutical Company.